menu Search
NEW
Beova

Beova

vibegron

Manufacturer:

Eisai

Distributor:

Zuellig

Marketer:

HI-Eisai
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Vibegron
Indications/Uses
Symptoms associated w/ overactive bladder eg, urinary urgency, urinary frequency & urge incontinence.
Click to view Beova detailed prescribing information
Dosage/Direction for Use
Adult 50 mg once daily.
Click to view Beova detailed prescribing information
Overdosage
View Beova overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take after meal.
Contraindications
History of hypersensitivity.
Click to view Beova detailed prescribing information
Special Precautions
Confirm clinical symptoms & exclude other diseases w/ similar symptoms (eg, UTI, urinary calculus, lower urinary tract neoplasm eg, bladder & prostate cancer) in diagnosis prior to use. May aggravate symptoms in patients w/ severe cardiac disease. Blood conc may be increased in patients w/ advanced hepatic impairment. Pregnancy & lactation. Administer w/ care while monitoring condition in the elderly.
Click to view Beova detailed prescribing information
Use In Pregnancy & Lactation
Click to view Beova detailed prescribing information
Adverse Reactions
Dry mouth, constipation; UTI (eg, cystitis), increased residual urine vol. Photophobia; increased AST & ALT.
Click to view Beova detailed prescribing information
Drug Interactions
Blood conc may be increased w/ CYP3A4 & P-gp inhibitors eg, azole antifungals (eg, itraconazole) & HIV PIs (eg, ritonavir). Blood conc may be decreased w/ CYP3A4 & P-gp inducers eg, rifampicin, phenytoin, carbamazepine.
Click to view Beova detailed prescribing information
Storage
View Beova storage conditions for details to ensure optimal shelf-life.
Description
View Beova description for details of the chemical structure and excipients (inactive components).
Action
View Beova mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04BD15 - vibegron ; Belongs to the class of urinary antispasmodics.
Regulatory Classification
Rx
Presentation/Packing
Form
Beova FC tab 50 mg
Packing/Price
28's